Atlas Trials

A Study Evaluating Safety and Pharmacokinetics of FPA144 in Japanese Patients With Advanced Gastric or Gastroesophageal Cancer

Clinical trial NCT05913115 · COMPLETED

Trial details

NCT number
NCT05913115
Sponsor
Amgen
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Gastric or Gastroesophageal Cancer
Start date
2017-06-12
Primary completion
2018-06-19
Enrollment
6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.